Colorectal Cancer

Heavy Alcohol Use Strongly Associated with Risk of Early-onset Colorectal Cancer, Study Finds
June 01, 2022

New research shows excessive alcohol use is strongly associated with an increased risk for colorectal cancer, regardless of genetic risk.

Sugar-sweetened Drink Consumption May Increase Risk for Early-onset Colorectal Cancer
May 07, 2021

A new study found that women who consumed ≥2 servings/day of sugar-sweetened beverages had a 2.2-fold higher risk for early onset CRC vs those who had less than 1 serving/week.

New USPSTF Colorectal Cancer Screening Draft Recommendation Includes Adults Aged 45 Years
October 28, 2020

For the first time, the USPSTF recommends colorectal cancer screening in adults beginning at age 45.

A Nutty Way to Prevent Cancer?
June 25, 2015

A large review ties nut consumption to a lower incidence of cancer, but not diabetes.

Follow-up Colonoscopy: When Should This Patient Return?
April 09, 2015

Is a surveillance interval of 1 year, 3 years, 5, or 10 years recommended?

Serrated Adenomas Found in Patients With IBD
November 11, 2010

Certain patients with inflammatory bowel disease are at heightened risk for the development of colorectal cancer. But researchers have not yet been able to discover markers that can identify these patients.

New Lymphadenopathy in a Woman With a History of Colon Cancer
September 01, 2007

A 47-year-old woman who recently completed adjuvant chemotherapy for colon cancer has painless cervical lymphadenopathy of 1 to 2 cm. She has no fever, sore throat, cough, or unexplained weight loss, and she denies exposure to ill persons or animals.

Colorectal Cancer Screening: Which Tests, How Often?
February 01, 2007

ABSTRACT: Screening options for colorectal cancer (CRC) include colonoscopy every 10 years, annual fecal occult blood testing, flexible sigmoidoscopy every 5 years, or double contrast barium enema every 5 years. In white patients at average risk, screening should begin at age 50; in African American patients, at age 45. Colonoscopy is preferred to sigmoidoscopy because it can detect proximal neoplasms and has the longest protection interval. High-risk patients include those with a family history of CRC or adenomas. These persons should begin colonoscopic screening at age 40, or 10 years earlier than the age at which CRC or adenomas were diagnosed in a first-degree relative. Other high-risk patients are those with a personal history of CRC, a genetic syndrome, or inflammatory bowel disease. In patients with CRC, the first follow-up colonoscopy is performed 1 year after surgery. If results are normal, the interval can be extended to every 3 years.

What’s Emerging on the Market and Under the Microscope?
January 01, 2007

The FDA has approved injectable Acetadote (acetylcysteine)from Cumberland Pharmaceuticals Incto prevent or lessen liver damage resulting from an overdoseof acetaminophen. According to the FDA, unintentionalacetaminophen overdose is responsible for 100deaths and 56,000 emergency department visits per year.

January 01, 2007

As the population ages, physicians are seeing a greaternumber of patients with colorectal disorders. This book combinesan up-to-date survey of the latest basic and clinicalresearch in the field with practical advice for the day-to-daycare of patients with colonic diseases. The first section ofthe book covers current knowledge of normal colorectal physiology.Section 2 discusses the basic disease mechanismsinvolved in colonic disorders and reviews the uses of suchinvestigational tools as colonoscopy, colonic biopsy, anorectalmanometry, ultrasonography, motility measurement,defecography, CT, and MRI. The third section offers a fulldiscussion of the diagnosis and treatment of commoncolonic disorders, including colorectal neoplasia, inflammatorybowel disease, ulcerative colitis, diverticular disease,Crohn disease, constipation, and irritable bowel syndrome.In addition to currently recommended approaches to evaluationand treatment, chapters in this section include discussionof advanced and investigational therapies.